INTERPACE BIOSCIENCES, INC. (IDXG)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 29, 2026

Verified against EDGAR
Total Assets
$34.5M
Stockholders' Equity
$23.2M
Cash & Equivalents
$2.7M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, INTERPACE BIOSCIENCES, INC. reported revenue of $9.1M, net income of $158,000, and total assets of $34.5M. Every figure below is taken directly from INTERPACE BIOSCIENCES, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$46.9M$10.1M-$26.7M
FY2016FY2019FY2022FY2025
Revenue$38.7MNet income$24.6M
FY2016 revenue
$13.1M
FY2025 revenue
$38.7M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$38.7M$24.6M
FY2024$46.9M$6.7M
FY2023$40.0M$2.0M
FY2022$31.8M-$22.0M
FY2021$33.1M-$14.9M
FY2020$32.4M-$26.5M
FY2019$24.2M-$26.7M
FY2018$21.9M-$12.2M
FY2017$15.9M-$12.2M
FY2016$13.1M-$8.3M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 15, 2026on EDGAR ↗
S-1Sep 25, 2026on EDGAR ↗
8-KAug 27, 2026on EDGAR ↗
8-KAug 20, 2026on EDGAR ↗
8-KAug 12, 2026on EDGAR ↗
10-QAug 10, 2026on EDGAR ↗
DEF 14AJul 7, 2026on EDGAR ↗
8-KMay 14, 2026on EDGAR ↗
10-QMay 12, 2026on EDGAR ↗
10-K/AApr 30, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$34.5Msource ↗
Stockholders’ Equity$23.2Msource ↗
Cash & Equivalents$2.7Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$9.1Msource ↗
Net Income$158,000source ↗
Operating Income$321,000source ↗
Gross Profit$5.7Msource ↗
Cost of Revenue$3.5Msource ↗
R&D Expense$149,000source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$0.01source ↗
EPS (basic)$0.01source ↗
Shares Outstanding27.7Msource ↗
Cash from Operations$98,000source ↗
Cash from Financing—source ↗
Cash from Investing-$57,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

No open-market Form 4 transactions filed in the last 180 days.

Restatement history

Point-in-time

76 of 554 annual fact-keys were materially restated between filings: what INTERPACE BIOSCIENCES, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches IDXG’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IDXG

MCP tool: get_sec_fundamentals ticker=IDXG

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IDXG/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=IDXG as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IDXG/history

MCP tool: get_fundamentals_history ticker=IDXG

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/IDXG

MCP tool: get_financial_health ticker=IDXG

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.